FDA seeks input on Makary’s voucher pilotnews2026-03-20T17:56:56+00:00March 20th, 2026|Endpoints News|
Top HHS official tamps down expectations on scope of TrumpRxnews2026-03-20T16:45:24+00:00March 20th, 2026|Endpoints News|
Sarepta to ask FDA for full approval of exon skipping drugs; Rhythm’s label expansion in rare form of obesitynews2026-03-20T15:21:54+00:00March 20th, 2026|Endpoints News|
China-rooted AI biotech Earendil Labs raises $787M ahead of possible IPOnews2026-03-20T15:16:10+00:00March 20th, 2026|Endpoints News|
UK’s NICE revisits Lilly, Eisai Alzheimer’s drugs under new pricing thresholdnews2026-03-20T14:51:59+00:00March 20th, 2026|Endpoints News|
Novo Holdings CEO discusses investments, geopolitics and Chinanews2026-03-20T12:00:34+00:00March 20th, 2026|Endpoints News|
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovationnews2026-03-20T11:40:21+00:00March 20th, 2026|Endpoints News|
Idorsia looks for another CEO — again; Former Jazz exec makes a comebacknews2026-03-20T11:00:00+00:00March 20th, 2026|Endpoints News|
Genentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trialnews2026-03-20T10:42:18+00:00March 20th, 2026|Endpoints News|
Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refutednews2026-03-20T00:26:49+00:00March 20th, 2026|Endpoints News|
